New Market Research Report: Neuralstem, Inc. (CUR) - Financial and Strategic SWOT Analysis Review

The company develops and markets medicines based on human neural stem cell technology and cell therapy. It provides cell therapy treatment for ALS, ischemic stroke, spinal cord injury, glioblastoma, multiple sclerosis, optic neuritis, Alzheimeri 1 2s disease, traumatic brain injury, peripheral nerve injury, diabetic neuropathy, lysosomal disease, Parkinsoni 1 2s disease, Huntingtoni 1 2s disease, and cerebral palsy.

http://ift.tt/1tSEpcE